Saidi S. Gaibov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saidi S. Gaibov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A. I Khrupa
Regional Clinical Hospital №2, Tyumen, Russian Federation
1 shared publication - Amirhossein Hosseini
Sechenov First Moscow State Medical University, Moscow, Russian Federation
1 shared publication - Dmitry E. Zakondyrin
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - Eduard Evgenievich Rostorguev
National Medical Research Centre for Oncology, Rostov-on-Don, Russia
1 shared publication - Konstantin Sergeevich Sergeev
Tyumen State Medical University, Tyumen, Russian Federation
1 shared publication - Myasnik A. Arabhanyan
Regional Clinical Hospital №2, Tyumen, Russian Federation
1 shared publication
Latest Publications
- 18 May 2026
- Published by Springer Nature in European Spine Journal
- p. 1-11
Endovascular–microsurgical treatment of hypervascular spinal tumors: influence of cervical, thoracic, and lumbar vascular anatomy on embolization decisions and primary clinical outcomes (25-case series)
Objective To assess whether preoperative spinal angiography with endovascular embolization followed by microsurgical resection is technically feasible and safe for hypervascular spinal tumors, and to examine how cervical, thoracic, and lumbar vascular anatomy influences feasibility. Methods We retrospectively reviewed 25 patients treated from 2017 to 2025 at two centers (14 men, 11 women; mean age 53 years) with hypervascular tumors involving the cervical (n = 3), thoracic (n = 15), lumbar and sacral (n = 7) spine. All underwent preoperative angiography (DSA)-embolization (within the same procedure if technically possible). We recorded whether embolization could be safely performed and any embolization-related complications; we also graded angiographic devascularization (devascularization grade, DG) and operative estimated blood loss (EBL). Selective or super-selective embolization was performed when arterial anatomy allowed safe catheterization, and surgery followed within 24–48 h. Results Embolization was feasible in 23/25 patients (92%): thoracic 15/15 (100%), lumbar 6/6 (100%), sacral 1/1 (100%), and cervical 1/3 (33%). Two cervical RCC (renal cell carcinoma) metastases were not embolized because multiple short feeders shared trunks with radiculomedullary (spinal cord–supplying) arteries, precluding safe super-selective access. Among embolized cases, super-selective feeder occlusion was performed in 5/23 (21.7%) and segmental-vessel embolization in 18/23 (78.3%) using precipitating hydrophobic injectable liquid (PHIL), coils, and n-butyl cyanoacrylate (NBCA). High-grade devascularization (DG2–3) was achieved in all embolized cases, and completion angiography showed no or minimal residual tumor blush. There were no permanent embolization-related neurological deficits (0/23); one transient ischemic event occurred (1/23, 4.3%; vertebrobasilar ischemia in a C2 aneurysmal bone cyst) with full recovery. Mean estimated blood loss was 650 mL (median 600; range 400–800 mL. Differences in mean EBL between subsets of RCC and non-RCC tumors were statistically unsignificant, Correlations between DG and EBL was not identified. Conclusion A coordinated endovascular–surgical pathway achieved high embolization feasibility with no permanent embolization-related neurological complications, and no postoperative neurological deterioration in this cohort. Feasibility limitations were concentrated in the cervical spine, where short, shared feeders involving spinal cord–supplying arteries can preclude safe embolization. Limitations include retrospective design, small cohort with few cervical cases, and heterogeneous tumors/embolic agents; prospective studies with standardized devascularization and functional outcome metrics are warranted.
- 18 May 2026
- Published by Springer Nature in European Spine Journal
- p. 1-11
Endovascular–microsurgical treatment of hypervascular spinal tumors: influence of cervical, thoracic, and lumbar vascular anatomy on embolization decisions and primary clinical outcomes (25-case series)
Objective To assess whether preoperative spinal angiography with endovascular embolization followed by microsurgical resection is technically feasible and safe for hypervascular spinal tumors, and to examine how cervical, thoracic, and lumbar vascular anatomy influences feasibility. Methods We retrospectively reviewed 25 patients treated from 2017 to 2025 at two centers (14 men, 11 women; mean age 53 years) with hypervascular tumors involving the cervical (n = 3), thoracic (n = 15), lumbar and sacral (n = 7) spine. All underwent preoperative angiography (DSA)-embolization (within the same procedure if technically possible). We recorded whether embolization could be safely performed and any embolization-related complications; we also graded angiographic devascularization (devascularization grade, DG) and operative estimated blood loss (EBL). Selective or super-selective embolization was performed when arterial anatomy allowed safe catheterization, and surgery followed within 24–48 h. Results Embolization was feasible in 23/25 patients (92%): thoracic 15/15 (100%), lumbar 6/6 (100%), sacral 1/1 (100%), and cervical 1/3 (33%). Two cervical RCC (renal cell carcinoma) metastases were not embolized because multiple short feeders shared trunks with radiculomedullary (spinal cord–supplying) arteries, precluding safe super-selective access. Among embolized cases, super-selective feeder occlusion was performed in 5/23 (21.7%) and segmental-vessel embolization in 18/23 (78.3%) using precipitating hydrophobic injectable liquid (PHIL), coils, and n-butyl cyanoacrylate (NBCA). High-grade devascularization (DG2–3) was achieved in all embolized cases, and completion angiography showed no or minimal residual tumor blush. There were no permanent embolization-related neurological deficits (0/23); one transient ischemic event occurred (1/23, 4.3%; vertebrobasilar ischemia in a C2 aneurysmal bone cyst) with full recovery. Mean estimated blood loss was 650 mL (median 600; range 400–800 mL. Differences in mean EBL between subsets of RCC and non-RCC tumors were statistically unsignificant, Correlations between DG and EBL was not identified. Conclusion A coordinated endovascular–surgical pathway achieved high embolization feasibility with no permanent embolization-related neurological complications, and no postoperative neurological deterioration in this cohort. Feasibility limitations were concentrated in the cervical spine, where short, shared feeders involving spinal cord–supplying arteries can preclude safe embolization. Limitations include retrospective design, small cohort with few cervical cases, and heterogeneous tumors/embolic agents; prospective studies with standardized devascularization and functional outcome metrics are warranted.